These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 32109249)

  • 1. miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma.
    Trilla-Fuertes L; Miranda N; Castellano D; López-Vacas R; Farfán Tello CA; de Velasco G; Villacampa F; López-Camacho E; Prado-Vázquez G; Zapater-Moros A; Espinosa E; Fresno Vara JÁ; Pinto Á; Gámez-Pozo A
    PLoS One; 2020; 15(2):e0229075. PubMed ID: 32109249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
    Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
    Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
    Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
    PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 7. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic MicroRNAs Characterization in Clear Cell Renal Cell Carcinoma.
    Petrozza V; Carbone A; Bellissimo T; Porta N; Palleschi G; Pastore AL; Di Carlo A; Della Rocca C; Fazi F
    Int J Mol Sci; 2015 Dec; 16(12):29219-25. PubMed ID: 26670229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA profiling of human kidney cancer subtypes.
    Petillo D; Kort EJ; Anema J; Furge KA; Yang XJ; Teh BT
    Int J Oncol; 2009 Jul; 35(1):109-14. PubMed ID: 19513557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C; Matsuura K; Tsukamoto Y; Tanigawa M; Yoshimoto T; Narimatsu T; Nguyen LT; Hijiya N; Uchida T; Sato F; Mimata H; Seto M; Moriyama M
    J Pathol; 2008 Dec; 216(4):418-27. PubMed ID: 18925646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
    Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
    Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
    Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
    Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma.
    Ge YZ; Xin H; Lu TZ; Xu Z; Yu P; Zhao YC; Li MH; Zhao Y; Zhong B; Xu X; Zhou LH; Wu R; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
    Sci Rep; 2015 May; 5():10328. PubMed ID: 25981392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
    Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
    Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated microRNA-185 is associated with high vascular endothelial growth factor receptor 2 expression levels and high microvessel density in clear cell renal cell carcinoma.
    Yuan HX; Zhang JP; Kong WT; Liu YJ; Lin ZM; Wang WP; Guo JM
    Tumour Biol; 2014 Dec; 35(12):12757-63. PubMed ID: 25217984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinoma.
    Friedrich M; Heimer N; Stoehr C; Steven A; Wach S; Taubert H; Hartmann A; Seliger B
    Sci Rep; 2020 Apr; 10(1):6499. PubMed ID: 32300145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
    Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
    Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated microRNA and mRNA Signature Associated with the Transition from the Locally Confined to the Metastasized Clear Cell Renal Cell Carcinoma Exemplified by miR-146-5p.
    Wotschofsky Z; Gummlich L; Liep J; Stephan C; Kilic E; Jung K; Billaud JN; Meyer HA
    PLoS One; 2016; 11(2):e0148746. PubMed ID: 26859141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.